These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 27004299)
1. Benefits of Allopurinol Treatment on Blood Pressure and Renal Function in Patients with Early Stage of Chronic Kidney Disease. Satirapoj B; Wirajit O; Burata A; Supasyndh O; Ruangkanchanasetr P J Med Assoc Thai; 2015 Dec; 98(12):1155-61. PubMed ID: 27004299 [TBL] [Abstract][Full Text] [Related]
2. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease. Ghane Sharbaf F; Assadi F Pediatr Nephrol; 2018 Aug; 33(8):1405-1409. PubMed ID: 29549464 [TBL] [Abstract][Full Text] [Related]
3. The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia. Tsuji T; Ohishi K; Takeda A; Goto D; Sato T; Ohashi N; Fujigaki Y; Kato A; Yasuda H Clin Exp Nephrol; 2018 Dec; 22(6):1300-1308. PubMed ID: 29700702 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Allopurinol on Renal Function. Krishnamurthy A; Lazaro D; Stefanov DG; Blumenthal D; Gerber D; Patel S J Clin Rheumatol; 2017 Jan; 23(1):1-5. PubMed ID: 28002149 [TBL] [Abstract][Full Text] [Related]
5. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP; Leung KT; Tong MK; Kwan TH Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [TBL] [Abstract][Full Text] [Related]
6. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838 [TBL] [Abstract][Full Text] [Related]
7. Comparison of renoprotective effects of febuxostat and allopurinol in hyperuricemic patients with chronic kidney disease. Lee JW; Lee KH Int Urol Nephrol; 2019 Mar; 51(3):467-473. PubMed ID: 30604229 [TBL] [Abstract][Full Text] [Related]
8. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Kanbay M; Ozkara A; Selcoki Y; Isik B; Turgut F; Bavbek N; Uz E; Akcay A; Yigitoglu R; Covic A Int Urol Nephrol; 2007; 39(4):1227-33. PubMed ID: 17701281 [TBL] [Abstract][Full Text] [Related]
10. Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease. Sakai Y; Otsuka T; Ohno D; Murasawa T; Sato N; Tsuruoka S Ren Fail; 2014 Mar; 36(2):225-31. PubMed ID: 24152124 [TBL] [Abstract][Full Text] [Related]
11. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study. Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979 [TBL] [Abstract][Full Text] [Related]
12. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia. Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for hyperuricemia in hypertensive patients. Gois PH; Souza ER Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832 [TBL] [Abstract][Full Text] [Related]
14. Study of therapeutic efficacy of febuxostat in chronic kidney disease stage IIIA to stage VD. Sarvepalli PS; Fatima M; Quadri AK; Taher AR; Habeeb A; Amreen F; Parveen BN; Rajaram KG Saudi J Kidney Dis Transpl; 2018; 29(5):1050-1056. PubMed ID: 30381500 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function. Bove M; Cicero AFG; Borghi C Curr Hypertens Rep; 2017 Oct; 19(12):95. PubMed ID: 29071435 [TBL] [Abstract][Full Text] [Related]
16. Effects of topiroxostat in hyperuricemic patients with chronic kidney disease. Horino T; Hatakeyama Y; Ichii O; Matsumoto T; Shimamura Y; Inoue K; Terada Y; Okuhara Y Clin Exp Nephrol; 2018 Apr; 22(2):337-345. PubMed ID: 28752287 [TBL] [Abstract][Full Text] [Related]
17. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. Feig DI; Soletsky B; Johnson RJ JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266 [TBL] [Abstract][Full Text] [Related]
18. Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD). Sezai A; Soma M; Nakata K; Osaka S; Ishii Y; Yaoita H; Hata H; Shiono M J Cardiol; 2015 Oct; 66(4):298-303. PubMed ID: 25649025 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease . Kwak CH; Sohn M; Han N; Cho YS; Kim YS; Oh JM Int J Clin Pharmacol Ther; 2018 Jul; 56(7):321-327. PubMed ID: 29750634 [TBL] [Abstract][Full Text] [Related]
20. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial. McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]